Form 8-K · Current report
F5, Inc. 8-K, filed Jul 27, 2026
- Filed
- CIK
- 0001048695
- Accession no.
- 0001048695-26-000063
Summary
F5, Inc. reported third-quarter fiscal 2026 revenue of $865 million, up 11% year over year, with 19% product revenue growth, and raised its full-year fiscal 2026 outlook to approximately 9% to 10% revenue growth. CEO François Locoh-Donou attributed eight consecutive quarters of double-digit product growth to F5's role in application delivery and security for hybrid multicloud and AI-driven enterprise infrastructure.
Key points
- F5 reported third-quarter fiscal 2026 revenue of $865 million, up 11% from $780 million a year earlier.
- Systems revenue was $240 million, software revenue was $223 million, and services revenue was $402 million.
- GAAP net income was $208 million, or $3.62 per diluted share; non-GAAP net income was $272 million, or $4.73 per diluted share.
- F5 raised its fiscal 2026 outlook to approximately 9% to 10% revenue growth and non-GAAP EPS of $17.21 to $17.33, and guided fourth-quarter revenue to $870 million to $890 million.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition On July 27, 2026, F5, Inc. (the "Company" or "F5") issued a press release regarding its financial results for the third quarter ended June 30, 2026. The press release is attached hereto as Exhibit 99.1. The information in the press release shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended. Item 9.01 Financial Statements and Exhibits (d) Exhibits: 99.1 Press Release of F5, Inc. announcing quarterly earnings dated July 27, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.